Georges Jourdi

1.1k total citations
36 papers, 418 citations indexed

About

Georges Jourdi is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Georges Jourdi has authored 36 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 14 papers in Internal Medicine and 12 papers in Hematology. Recurrent topics in Georges Jourdi's work include Atrial Fibrillation Management and Outcomes (15 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Georges Jourdi is often cited by papers focused on Atrial Fibrillation Management and Outcomes (15 papers), Venous Thromboembolism Diagnosis and Management (14 papers) and Blood Coagulation and Thrombosis Mechanisms (9 papers). Georges Jourdi collaborates with scholars based in France, Canada and United States. Georges Jourdi's co-authors include Pascale Gaussem, Marie Lordkipanidzé, Isabelle Gouin‐Thibault, Ismaı̈l Elalamy, Virginie Siguret, Jawed Fareed, Debra Hoppensteadt, Grigoris Gerotziafas, Amanda Walborn and Priya Patel and has published in prestigious journals such as International Journal of Molecular Sciences, Critical Care Medicine and Biochemical Pharmacology.

In The Last Decade

Georges Jourdi

32 papers receiving 408 citations

Peers

Georges Jourdi

CCM

HEMAT

SURGE

EPIDE

Emmanuelle Jeanpierre France

Siavash Piran Canada

Paul Billoir France

S. Miranda France

S Gavasso Italy

Rashid Kazmi United Kingdom

Catherine Rea United Kingdom

Tutomu Nakase Japan

Janet Brennand United Kingdom

J Wilde United Kingdom

Emmanuelle Jeanpierre France

Georges Jourdi

111 ×0.7

CCM

48 ×0.3

106 ×0.9

HEMAT

66 ×1.0

SURGE

55 ×1.0

EPIDE

Citations per year, relative to Georges Jourdi Georges Jourdi (= 1×) peers Emmanuelle Jeanpierre

Countries citing papers authored by Georges Jourdi

Since Specialization

Citations

This map shows the geographic impact of Georges Jourdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georges Jourdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georges Jourdi more than expected).

Fields of papers citing papers by Georges Jourdi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georges Jourdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georges Jourdi. The network helps show where Georges Jourdi may publish in the future.

Co-authorship network of co-authors of Georges Jourdi

This figure shows the co-authorship network connecting the top 25 collaborators of Georges Jourdi. A scholar is included among the top collaborators of Georges Jourdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georges Jourdi. Georges Jourdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jourdi, Georges, Claire Flaujac, Emmanuel de Maistre, et al.. (2025). Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals. Thrombosis and Haemostasis.

Jourdi, Georges, et al.. (2024). The intriguing role of platelets as custodians of brain-derived neurotrophic factor. Research and Practice in Thrombosis and Haemostasis. 8(3). 102398–102398. 5 indexed citations

Schreuder, Mark, Georges Jourdi, David A. Poole, et al.. (2024). Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors. Journal of Thrombosis and Haemostasis. 22(8). 2211–2226. 1 indexed citations

Gendron, Nicolas, Paul Billoir, Virginie Siguret, et al.. (2024). Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants?. Thrombosis Research. 237. 171–180. 8 indexed citations

Jourdi, Georges, Jean‐Sébastien Hulot, & Pascale Gaussem. (2024). An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks?. Expert Opinion on Drug Metabolism & Toxicology. 20(8). 749–764. 4 indexed citations

Siguret, Virginie, et al.. (2024). Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review. Current Opinion in Hematology. 32(1). 22–33.

Larréché, Sébastien, Aurore Bousquet, L Chevillard, et al.. (2023). Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms. Toxins. 15(10). 614–614. 5 indexed citations

Jourdi, Georges, et al.. (2023). Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?. Neural Regeneration Research. 19(3). 536–541. 6 indexed citations

Jourdi, Georges, Michael P. Gantier, Justin R. Hamilton, et al.. (2023). Megakaryocytes possess a STING pathway that is transferred to platelets to potentiate activation. Life Science Alliance. 7(2). e202302211–e202302211. 6 indexed citations

10.

Jourdi, Georges, et al.. (2023). Alpha-2-macroglobulin prevents platelet aggregation induced by brain-derived neurotrophic factor. Biochemical Pharmacology. 215. 115701–115701. 2 indexed citations

11.

Jourdi, Georges, Anne Godiér, Marie Lordkipanidzé, Guillaume Marquis‐Gravel, & Pascale Gaussem. (2022). Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches. Frontiers in Cardiovascular Medicine. 9. 805525–805525. 18 indexed citations

12.

Jourdi, Georges, Guillaume Marquis‐Gravel, Anne‐Céline Martin, et al.. (2022). Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines. Frontiers in Pharmacology. 13. 878416–878416. 4 indexed citations

13.

Jourdi, Georges, Marie Lordkipanidzé, Aurélien Philippe, Christilla Bachelot‐Loza, & Pascale Gaussem. (2021). Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases. International Journal of Molecular Sciences. 22(23). 13079–13079. 36 indexed citations

14.

Jourdi, Georges, Virginie Siguret, Xavier Declèves, et al.. (2021). Induced forms of α2-macroglobulin neutralize heparin and direct oral anticoagulant effects. International Journal of Biological Macromolecules. 184. 209–217. 6 indexed citations

15.

Duchemin, Jérôme, et al.. (2021). A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter. Frontiers in Medicine. 8. 683357–683357. 15 indexed citations

16.

Jourdi, Georges, Caroline Vayne, Alexandre Godon, et al.. (2020). Anticoagulation therapy in France: state-of-the-art in 2020. Annals of Blood. 5. 3–3. 6 indexed citations

17.

Jourdi, Georges, Bernard Le Bonniec, & Isabelle Gouin‐Thibault. (2019). Strategies of neutralization of the direct oral anticoagulants effect: review of the literature. Annales de biologie clinique. 77(1). 67–78. 5 indexed citations

18.

Jourdi, Georges, Maxime Delrue, Alain Stépanian, et al.. (2019). Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants. Thrombosis Research. 184. 86–91. 33 indexed citations

19.

Pailleret, Claire, Georges Jourdi, Virginie Siguret, et al.. (2018). Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood. European Journal of Anaesthesiology. 36(6). 449–456. 20 indexed citations

20.

Jourdi, Georges, Virginie Siguret, Anne‐Céline Martin, et al.. (2015). Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban. Thrombosis and Haemostasis. 114(7). 78–86. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact